Skip to main content
. 2020 Dec 21;64(1):26–41. doi: 10.1021/acs.jmedchem.0c00931

Figure 3.

Figure 3

Design strategy leading to the discovery of dual GSK-3β/BACE-1 inhibitor 1. Triazinones were obtained combining structural features responsible for GSK-3β and BACE-1 inhibition, a cyclic amide and a guanidino moiety, respectively. Compound 1 is the most interesting of the series with an IC50 in the micromolar range against both proteins.